Three-year data from a comparative study with recombinant human growth hormone in the treatment of short stature in young children with intrauterine growth retardation

Acta Paediatrica, International Journal of Paediatrics

Volumn 87, Issue 5, 1998, Pages 511-517

  Fjellestad Paulsen, A ^a   Czernichow, P ^a   Brauner, R ^b   Bost, M ^c   Colle, M ^d   Lebouc, J Y ^e   Lecornu, M ^f   Leheup, B ^g   Limal, J M ^h   Raux, M C ^e   Toublanc, J E ⁱ   Rappaport, R ^b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d Trousseau ^*  (France)

^e ARMAND TROUSSEAU HOSPITAL   (France)

^f SERVICE DE RHUMATOLOGIE   (France)

^g CHU NANCY BRABOIS   (France)

^h RENNES UNIVERSITY HOSPITAL   (France)

ⁱ HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

Growth hormone treatment; Intrauterine growth retardation; Short stature

Indexed keywords

HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE;

ARTICLE; BONE MATURATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; GROWTH ACCELERATION; HORMONAL THERAPY; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT STATURE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 15444361239     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035259850158209     Document Type: Article

References (33)

1. Thizon de Gaulle I, Léger J, Czernichow P. Retard de croissance intra-utérin: croissance postnatale et facteurs de croissance. Journées Parisiennes de Pédiatrie. Paris: Ed. Flammarion, 1992: 63-70
2. Albertsson-Wikland K, Wennergren G, Wennergren M, Vilbergsson G, Rosberg S. Longitudinal follow-up of growth in children born small for gestational age. Acta Paediatr 1993; 82: 438-43
3. Léger J, Limoni C, Czernichow P. Prediction of the outcome of growth at 2 years of age in neonates with intrauterine growth retardation. Early Hum Dev 1997; 48: 211-23
4. Fancourt R, Campbell S, Harvey D, Normal AP. Follow up study of small-for-date babies. Br Med J 1976; 1: 1435-7
5. Davies DP. Growth of 'small for date' babies. Early Hum Dev 1981; 5: 95-105
6. Ounsted M, Moar V, Scott A. Growth in the firsl four years: Diversity within groups of small-tor-dates and large-for-dates babies. Early Hum Dev 1982; 7: 29-39
7. Tenovuo A, Kero P, Piekkala P, Korvenranta H, Sillanpaa M, Erkkola R. Growth of 519 small for gestational age infants during the first 2 years of life. Acta Paediatr Scand 1987; 76: 636-46
8. Fitzhardinge PM, Inwood S. Long-term growth in small-for-date children. Acta Paediatr Scand 1989; 349: 27-33
9. Westwood M, Kramer CK, Munz D, Lovett JM, Watters GV. Growth and development of full-term nonasphysiated small-for-gestational age newborns: follow-up through adolescence. Pediatrics 1983; 71: 376-82
10. Nilsen ST, Finne PH, Bergsjo P, Stammes O. Males with low birth-weight examined at 18 years of age. Acta Paediatr Scand 1984; 73: 168-75
11. Job JC, Rolland A. Histoire naturelle des retards de croissance: début intra-utérin. Arch Fr Pediat 1986; 43: 301-6
12. Schauseil-Zipf U, Hamm W, Boite A, Gladtke E. Severe intra-uterine growth retardation: obstetrical management and follow-up studies in children born between 1970 and 1985. Eur J Obstet Gynccol Bid 1989; 30: 1-9
13. Paz I, Seidman DS, Danon YL, Laor A, Stevenson DK, Gale R. Are children bom small-for-gestational age at increased risk of short stature? Am J Dis Childhood 1993; 147: 337-9
14. Albanese A, Stanhope R. Growth and metabolic data following growth hormone treatment of children with intrauterine growth retardation. Horm Res 1993; 39: 8-12
15. Job JC, Chaussain JL, Job B, Ducret JP, Maes M, Olivier M, et al. Follow-up of three years of treatment with growth hormone and of one post-treatment year, in children with severe growth retardation of intrauterine onset. Pediatr Res 1996; 39: 354-9
16. de Zegher F, Albertsson-Wikland K, Wilton P, Chatelain P, Jonsson B, Lofstrom A, et al. Growth hormone treatment of short children bom small for gestational age: metanalysis of four independant, randomized, controlled, multicentre studies. Acta Paediatr 1996; 417 Suppl: 27-31
17. Rosilio M, Carel JC, Blazy D, Chaussain JL. Growth hormone treatment of children with short stature secondary to intra-uterine growth retardation: effect of 2 years' treatment and 2 years' follow-up. Horm Res 1997; 48(suppl): 23-8
18. Boguszewski M, Bjarnason R, Rosberg S, Carlsson LMS, Alhertsson-Wikland K. Growth hormone (GH)-Binding protein in prepubertal short children bom small for gestational age: effects of growth hormone treatment. J Clin Endocrinol Metabol 1997; 82: 1014-1019
19. Sempé M, Pedron G, Roy-Pernot MP. Auxologie, méthodes et séquences. Paris: Theraplix, 1979
20. Leroy B, Lefort F. A propos du poids et de la taille des nouveaux nés à la naissance. Rev Fr Gynécol 1971; 66: 391-6
21. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford: Stanford University Press, 1959
22. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in girls. Arch Dis Child 1969: 44: 291-303
23. Marshall WA, Tanner JM. Variation in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45: 13-23
24. Zeisel HJ, Lutz A, Hennés ML, Petrykowski WV. Immunogenicity of mammalian-cell-derived recombinant human growth hormone preparations during long-term treatment. Horm Res 1992: 37 Suppl 2: 35-43
25. Rolland Cachera MF, Cole TJ, Sempé M, Tichet J, Rossignol C, Charraud A. Body mass index variations: centiles form birth to 87 years. Eur J Clin Nutr 1991; 45: 13-21
26. Karlberg J, Albertsson-Wikland K. Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res 1995; 38: 733-9
27. Blethen SL, Compton P, Lippe BM, Rosenfeld RG, August GP, Johanson A. Factors predicting the response to growth hormone (GH) therapy in prepubertal children with GH deficiency. J Clin Endocrinol Metabol 1993; 760: 574-9
28. Tanner JM, Lejarriaga H, Cameron N. The natural history of the Silver-Russel syndrome: a longitudinal study of 39 cases. Pediatr Res 1975; 9: 611-23
29. de Zegher F, Maes M, Gargosky SE, Heinrich L, Du Laju MVL, Thiry G, et al. High-dose growth hormone treatment of short children bom small for gestational age. Clin Endocrinol Metabol 1996; 81: 1887-92
30. Davies PSW, Valley R, Preece MA. Adolescent growth and pubertal progression in the Silver-Russel syndrome. Arch Dis Child 1988; 63: 130-5
31. Bougnères PF. High-dose growth hormone treatment of non-growth hormone-deficient children: preliminary results after 2 years. Acta Paediatr Scand 1990; 366 Suppl: 38-40
32. Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PMS. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36: 62-7
33. Leger J, Garel C, Legrand I, Paulsen A, Hassan M, Czernichow P. Magnetic resonance imaging evaluation of adipose tissue and muscle tissue mass in children with growth hormone (GH) deficiency, Turner's syndrome and intrauterine growth retardation during the first year of treatment with GH. J Clin Endocrinol Metabol 1994; 78: 904-9